All News IPH Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:41 2024-05-02 am EDT			5-day change	1st Jan Change
6.13 ^AUD	0.00%		-1.29%	-4.37%

Feb. 29	IPH Limited Announces Executive Changes	CI
Feb. 28	IPH Managing Director Pares Shareholding in Firm	MT

IPH Limited Announces Executive Changes	Feb. 29	CI
IPH Managing Director Pares Shareholding in Firm	Feb. 28	MT
Transcript : IPH Limited, H1 2024 Earnings Call, Feb 22, 2024	Feb. 21
IPH Reports H1 FY24 Revenue Up 22%, EPS of AU$0.0879	Feb. 21	MT
IPH Ltd. Reports H1 FY24 Revenue Up 21% to AU$274.4 Million; Underlying Diluted EPS of AU$0.212	Feb. 21	MT
IPH Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 21	CI
US FDA Ends Partial Clinical Hold on Innate Pharma's Investigational Cancer Drug	Jan. 04	MT
Sanofi Licenses Natural Killer Cell Engager Program from Innate Pharma	Dec. 19	MT
IPH Completes ROBIC Business Acquisition	Dec. 17	MT
IPH Limited completed the acquisition of ROBIC L.L.P.	Dec. 14	CI
IPH Announces Third Canadian Acquisition with AU$124 Million Deal	Nov. 22	MT
IPH Managing Director and CEO Sells Company Shares	Nov. 22	MT
IPH Limited entered into an agreement to acquire ROBIC L.L.P. for CAD 110 million.	Nov. 19	CI
IPH Limited Approves Election of Director, David Wiadrowski	Nov. 14	CI
IPH Limited Seeks Acquisitions	Nov. 14	CI
Transcript : IPH Limited - Shareholder/Analyst Call	Nov. 14
IPH Completes AU$75 Million Acquisition of Canadian IP Services Firm	23-10-01	MT
Australia Inc roiled by string of cyber attacks since late 2022	23-09-29	RE
IPH's Net Profit Jumps 23% in Fiscal Year 2023; Shares Rally 10%	23-08-17	MT
IPH Limited Seeks Acquisitions	23-08-16	CI

No results for this search